CARDLYTICS, INC.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-14.9M | $-4.5M | $-8.3M | $-72.7M | $-9.3M | $-13.3M | $-15.6M | $-145.2M |
| Depreciation & Amortization | $4.1M | $4.4M | $8.2M | $6.5M | $4.2M | $6.3M | $5.9M | $7.0M |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | $0 | $300.0K | $1.3M | $1.5M | $1.5M | $1.5M | $1.4M | $2.8M |
| Stock-Based Compensation | $2.4M | $4.8M | $5.5M | $6.4M | $7.5M | $8.7M | $8.7M | $8.1M |
| Net Cash from Operating Activities | $-8.6M | $-5.6M | $13.0M | $1.8M | $1.2M | $-6.7M | $3.0M | $1.4M |
| Investing Activities | ||||||||
| Capital Expenditures | $2.0K | $28.0K | $25.0K | $14.0K | $322.0K | $119.0K | $123.0K | $507.0K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $20.9M | $-2.3M | $-2.3M | $-4.5M | $-4.7M | $-3.9M | $-4.1M | $-5.3M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $-20.1M | $-5.0M | $-6.0M | $-12.0K | $-2.1M | $-3.0M | $-202.0K | $-388.0K |
| Net Change in Cash | $-7.6M | $-13.0M | $4.8M | $-2.8M | $-5.3M | $-13.5M | $-1.4M | $-4.3M |
| Free Cash Flow | $-8.6M | $-5.7M | $13.0M | $1.7M | $903.0K | $-6.8M | $2.9M | $878.0K |